Guidance

Hepatitis A/B vaccine: patient group direction template

Patient group direction (PGD) template to support the provision of hepatitis A and B (HepA/B) vaccine to individuals requiring protection against hepatitis A and hepatitis B.

From:
UK Health Security Agency
Published
13 November 2017
Last updated
16 October 2023 — See all updates

Applies to England

Documents

HepA/B vaccine PGD

Ref: UKHSA gateway number GOV-15400

MS Word Document, 160 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The HepA/B vaccine patient group direction (PGD) supports the provision of HepA/B vaccine to individuals aged one year and over who require immunisation against hepatitis A and B virus.

The HepA/B vaccine PGD version 4.00 is valid from 31 October 2023 to 31 October 2026.

Practitioners must not use these PGD templates until they have been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy or procedures to access authorised PGD documents.

These PGD templates should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 13 November 2017
Last updated 16 October 2023 + show all updates

  1. Updated review date.

  2. Added version 4.00 – see page 2 for change history.

  3. Added v03.00.

  4. The HepA/B vaccine (temp) PGD was withdrawn from 31 October 2020, on its expiry.

  5. Updated HepA/B vaccine patient group direction (PGD).

  6. Added routine update of the HepA/B vaccine (temp) PGD.

  7. First published.

Related content